Search research articles
Contact Us
Filters
Showing results (31-40 of 69) with videos related to
Page
of 7
Sort By:
Cancer
|
June 1, 1992
High-dose local irradiation plus prophylactic hepatic irradiation and chemotherapy for inoperable adenocarcinoma of the pancreas. A preliminary report of a multi-institutional trial (Radiation Therapy Oncology Group Protocol 8801)
R Komaki, S Wadler, T Peters, et al.
American Journal of Clinical Oncology
|
August 1, 1992
Intraoperative radiation therapy of extrahepatic biliary carcinoma: a report of RTOG-8506
H B Wolkov, G M Graves, M Won, et al.
Cancer
|
May 1, 1981
Local control of intrathoracic disease with chemotherapy and role of prophylactic cranial irradiation in small-cell carcinoma of the lung
R W Byhardt, J A Libnoch, J D Cox, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 1, 1997
Postoperative radiotherapy with concurrent cisplatin appears to improve locoregional control of advanced, resectable head and neck cancers: RTOG 88-24
M Al-Sarraf, T F Pajak, R W Byhardt, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 13, 2000
Interfraction interval does not affect survival of patients with non-small cell lung cancer treated with chemotherapy and/or hyperfractionated radiotherapy: a multivariate analysis of 1076 RTOG patients
M Werner-Wasik, C Scott, M L Graham, et al.
Radiology
|
July 1, 1994
Prostate cancer: are racial differences in clinical stage and survival explained by differences in symptoms?
C A Lawton, J E Cantrell, S W Derus, et al.
American Journal of Clinical Oncology
|
December 1, 1985
What is the lowest effective biologic dose for prophylactic cranial irradiation?
R Komaki, R W Byhardt, T Anderson, et al.
American Journal of Clinical Oncology
|
October 1, 1984
The prognostic significance of histologic subtyping in small cell carcinoma of the lung
H Choi, R W Byhardt, L J Clowry, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 7, 1998
Response, toxicity, failure patterns, and survival in five Radiation Therapy Oncology Group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non-small-cell carcinoma of the lung
R W Byhardt, C Scott, W T Sause, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 20, 1993
Interruptions of high-dose radiation therapy decrease long-term survival of favorable patients with unresectable non-small cell carcinoma of the lung: analysis of 1244 cases from 3 Radiation Therapy Oncology Group (RTOG) trials
J D Cox, T F Pajak, S Asbell, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 69) with videos related to
Sort By:
Page
of 7
Cancer
|
June 1, 1992
High-dose local irradiation plus prophylactic hepatic irradiation and chemotherapy for inoperable adenocarcinoma of the pancreas. A preliminary report of a multi-institutional trial (Radiation Therapy Oncology Group Protocol 8801)
R Komaki, S Wadler, T Peters, et al.
American Journal of Clinical Oncology
|
August 1, 1992
Intraoperative radiation therapy of extrahepatic biliary carcinoma: a report of RTOG-8506
H B Wolkov, G M Graves, M Won, et al.
Cancer
|
May 1, 1981
Local control of intrathoracic disease with chemotherapy and role of prophylactic cranial irradiation in small-cell carcinoma of the lung
R W Byhardt, J A Libnoch, J D Cox, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 1, 1997
Postoperative radiotherapy with concurrent cisplatin appears to improve locoregional control of advanced, resectable head and neck cancers: RTOG 88-24
M Al-Sarraf, T F Pajak, R W Byhardt, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 13, 2000
Interfraction interval does not affect survival of patients with non-small cell lung cancer treated with chemotherapy and/or hyperfractionated radiotherapy: a multivariate analysis of 1076 RTOG patients
M Werner-Wasik, C Scott, M L Graham, et al.
Radiology
|
July 1, 1994
Prostate cancer: are racial differences in clinical stage and survival explained by differences in symptoms?
C A Lawton, J E Cantrell, S W Derus, et al.
American Journal of Clinical Oncology
|
December 1, 1985
What is the lowest effective biologic dose for prophylactic cranial irradiation?
R Komaki, R W Byhardt, T Anderson, et al.
American Journal of Clinical Oncology
|
October 1, 1984
The prognostic significance of histologic subtyping in small cell carcinoma of the lung
H Choi, R W Byhardt, L J Clowry, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 7, 1998
Response, toxicity, failure patterns, and survival in five Radiation Therapy Oncology Group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non-small-cell carcinoma of the lung
R W Byhardt, C Scott, W T Sause, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 20, 1993
Interruptions of high-dose radiation therapy decrease long-term survival of favorable patients with unresectable non-small cell carcinoma of the lung: analysis of 1244 cases from 3 Radiation Therapy Oncology Group (RTOG) trials
J D Cox, T F Pajak, S Asbell, et al.
Page
of 7